Increasingly, providers and insurers are collaborating to manage chronic disease populations through the use of mobile apps. The data gathered by these apps (in real or near real-time) can be used by different segments of the healthcare industry towards the same goals: increasing the wellness of these patients. For a payer, this correlates to decrease in cost to service this member.
In this article, some mobile asthma apps have sensors that attach to a standard inhaler to monitor wheeze factors. Some other apps also collect de-identified patient information that includes patient location including where and when a reading of lung function occurs. Additional data such as specific medications, dosage, and number of times per day taken by the patient can also be collected by the app software.
One interesting use for all this big data when used in conjunction with other sources such as pollution data from the NOAA (National Oceanic and Atmospheric Administration) is to find direct relationships between pollutants and the rise in the need to asthma patients to take their medication.
How cool is that?
Not only can patient self-monitor based on this information, entities interested in population and disease management that now increasingly includes ACOs can leverage this information to better service this group.